CMCER

Canadian Medical Center Co.

4021StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	408.03M	439.67M	470.47M	566.72M	527.45M
Market Cap Growth	-20.0%	-17.4%	-13.3%	+29.4%	+5.1%
Enterprise Value	383.89M	411.37M	442.69M	534.43M	495.03M
Last Close Price	5.30	5.63	6.02	7.21	6.71
Valuation Multiples
PE Ratio	67.01	72.19	—	34.92	34.76
PS Ratio	2.61	2.82	3.17	4.22	4.33
PB Ratio	4.41	4.75	4.90	5.83	5.39
P/TBV Ratio	4.41	4.75	4.90	5.83	5.39
P/FCF Ratio	26.70	52.01	127.56	—	—
P/OCF Ratio	16.52	38.42	71.12	—	—
EV/Sales Ratio	2.46	2.63	2.99	3.98	4.06
EV/EBITDA Ratio	16.07	19.76	20.71	23.25	26.48
EV/EBIT Ratio	22.99	24.63	24.86	26.71	30.47
EV/FCF Ratio	25.12	48.67	120.03	—	—
Leverage & Capital
Debt / Equity Ratio	0.10	0.10	0.06	0.07	0.07
Debt / EBITDA Ratio	0.39	0.39	0.34	0.20	0.39
Debt / FCF Ratio	0.60	1.09	1.63	—	—
Net Debt / Equity Ratio	-0.26	-0.26	-0.30	-0.29	-0.33
Net Debt / EBITDA Ratio	-1.15	-1.16	-1.32	-1.21	-1.73
Net Debt / FCF Ratio	-1.58	-2.86	-7.67	12.25	—
Efficiency & Liquidity
Asset Turnover	1.11	1.34	1.28	—	—
Inventory Turnover	—	37.99	38.62	34.30	—
Quick Ratio	2.61	2.61	3.62	4.20	4.51
Current Ratio	3.11	3.11	4.00	4.64	5.04
Returns & Yields
Return on Equity (ROE)	+12.9%	-5.2%	+14.3%	—	+31.7%
Return on Assets (ROA)	+7.5%	+4.8%	+12.5%	—	—
Return on Invested Capital (ROIC)	+5.2%	+3.7%	+8.5%	+3.5%	+7.9%
Return on Capital Employed (ROCE)	+16.0%	+16.0%	+16.6%	+18.4%	+14.7%
Earnings Yield	+1.5%	+1.4%	+2.2%	+2.9%	+2.9%
FCF Yield	+3.7%	+1.9%	+0.8%	-0.4%	—
Dividend Yield	+3.0%	—	+2.2%	—	+1.5%
Payout Ratio	+126.4%	—	—	—	—
Buyback Yield / Dilution	0.0%	0.0%	—	—	—
Total Shareholder Return	+3.0%	0.0%	+2.2%	—	+1.5%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	408.03M	439.67M	470.47M	566.72M	527.45M
Market Cap Growth	-20.0%	-17.4%	-13.3%	+29.4%	+5.1%
Enterprise Value	383.89M	411.37M	442.69M	534.43M	495.03M
Last Close Price	5.30	5.63	6.02	7.21	6.71
Valuation Multiples
PE Ratio	67.01	72.19	—	34.92	34.76
PS Ratio	2.61	2.82	3.17	4.22	4.33
PB Ratio	4.41	4.75	4.90	5.83	5.39
P/TBV Ratio	4.41	4.75	4.90	5.83	5.39
P/FCF Ratio	26.70	52.01	127.56	—	—
P/OCF Ratio	16.52	38.42	71.12	—	—
EV/Sales Ratio	2.46	2.63	2.99	3.98	4.06
EV/EBITDA Ratio	16.07	19.76	20.71	23.25	26.48
EV/EBIT Ratio	22.99	24.63	24.86	26.71	30.47
EV/FCF Ratio	25.12	48.67	120.03	—	—
Leverage & Capital
Debt / Equity Ratio	0.10	0.10	0.06	0.07	0.07
Debt / EBITDA Ratio	0.39	0.39	0.34	0.20	0.39
Debt / FCF Ratio	0.60	1.09	1.63	—	—
Net Debt / Equity Ratio	-0.26	-0.26	-0.30	-0.29	-0.33
Net Debt / EBITDA Ratio	-1.15	-1.16	-1.32	-1.21	-1.73
Net Debt / FCF Ratio	-1.58	-2.86	-7.67	12.25	—
Efficiency & Liquidity
Asset Turnover	1.11	1.34	1.28	—	—
Inventory Turnover	—	37.99	38.62	34.30	—
Quick Ratio	2.61	2.61	3.62	4.20	4.51
Current Ratio	3.11	3.11	4.00	4.64	5.04
Returns & Yields
Return on Equity (ROE)	+12.9%	-5.2%	+14.3%	—	+31.7%
Return on Assets (ROA)	+7.5%	+4.8%	+12.5%	—	—
Return on Invested Capital (ROIC)	+5.2%	+3.7%	+8.5%	+3.5%	+7.9%
Return on Capital Employed (ROCE)	+16.0%	+16.0%	+16.6%	+18.4%	+14.7%
Earnings Yield	+1.5%	+1.4%	+2.2%	+2.9%	+2.9%
FCF Yield	+3.7%	+1.9%	+0.8%	-0.4%	—
Dividend Yield	+3.0%	—	+2.2%	—	+1.5%
Payout Ratio	+126.4%	—	—	—	—
Buyback Yield / Dilution	0.0%	0.0%	—	—	—
Total Shareholder Return	+3.0%	0.0%	+2.2%	—	+1.5%